They reported that although there was no effect of injection rate on doxorubicin distribution in the brain when transferrin-doxorubicin complexes were administered into normal tissues, the distribution was approximately 3-fold higher when the complexes were injected into tumor tissues at a slower rate. Here, TF is linked to neoplasm.